Electrode material for non-aqueous solvent-secondary cell, electrode and secondary cell
    2.
    发明授权
    Electrode material for non-aqueous solvent-secondary cell, electrode and secondary cell 有权
    用于非水溶剂二次电池,电极和二次电池的电极材料

    公开(公告)号:US07235329B2

    公开(公告)日:2007-06-26

    申请号:US11378300

    申请日:2006-03-20

    IPC分类号: H01M4/58

    摘要: An electrode material comprising a powdery mixture of a metal material (particularly, an intermetallic compound) and a capacitive carbon material each capable of doping and dedoping lithium, and an optionally added fine electroconductive additive, and containing the metal material and the capacitive carbon material in amounts of 5-60 wt. % and 40-95 wt. %, respectively, is used as an active substance for an electrode, particularly a negative electrode, of a non-aqueous solvent secondary cell. As a result, there is provided a non-aqueous solvent secondary cell which has large charge-discharge capacities, a small irreversible capacity determined as a difference between the doping capacity and the de-doping capacity, and also excellent cycle characteristics.

    摘要翻译: 一种电极材料,其包含金属材料(特别是金属间化合物)和能够掺杂和去掺杂锂的电容性碳材料的粉末混合物,以及任选加入的细导电添加剂,并且含有金属材料和电容性碳材料 用量5-60wt。 %和40-95wt。 %分别用作非水溶剂二次电池的电极,特别是负极的活性物质。 结果,提供了一种非水溶剂二次电池,其具有大的充电放电容量,小的不可逆容量被确定为掺杂容量和去掺杂能力之间的差异,并且还具有优异的循环特性。

    Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
    4.
    发明授权
    Adsorbent for oral administration, and agent for treating or preventing renal or liver disease 有权
    用于口服的吸附剂和用于治疗或预防肾或肝脏疾病的药剂

    公开(公告)号:US08920796B2

    公开(公告)日:2014-12-30

    申请号:US10969998

    申请日:2004-10-22

    CPC分类号: A61K33/44 Y10S514/893

    摘要: An adsorbent for an oral administration, comprising a surface-modified spherical activated carbon wherein an average diameter is 0.01 to 1 mm, a specific surface area determined by a BET method is 700 m2/g or more, a volume of pores having a pore diameter of 7.5 to 15000 nm is from 0.25 mL/g to 1.0 mL/g, a total amount of acidic groups is 0.30 to 1.20 meq/g, and a total amount of basic groups is 0.20 to 0.7 meq/g, is disclosed.

    摘要翻译: 一种用于口服给药的吸附剂,其包含平均直径为0.01至1mm的表面改性的球形活性炭,通过BET法测定的比表面积为700m 2 / g以上,具有孔径的孔的体积 7.5〜15000nm的范围为0.25mL / g〜1.0mL / g,酸性基团的总量为0.30〜1.20meq / g,碱性基团的总量为0.20〜0.7meq / g。

    Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
    5.
    发明授权
    Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease 有权
    用于口服给药的吸附剂和用于治疗或预防肾或肝脏疾病的药剂

    公开(公告)号:US08440228B2

    公开(公告)日:2013-05-14

    申请号:US11547003

    申请日:2005-04-04

    CPC分类号: A61K9/16 A61K33/44

    摘要: An adsorbent for an oral administration, comprising a spherical activated carbon wherein an average particle diameter is 50 to 200 μm, a specific surface area determined by a BET method is 700 m2/g or more, and a bulk density is less than 0.54 g/mL is disclosed. The adsorbent for an oral administration has a high adsorbability, and is capable of adsorbing a large amount of toxins during a retention period in an intestine, and of remarkably increasing an adsorption amount of compounds having a large molecular weight.

    摘要翻译: 用于口服给药的吸附剂,其包含平均粒径为50-200μm的球形活性炭,通过BET法测定的比表面积为700m 2 / g以上,堆积密度小于0.54g / mL。 用于口服的吸附剂具有高吸附性,并且能够在保留期间在肠中吸附大量的毒素,并且显着增加分子量大的化合物的吸附量。

    Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
    6.
    发明授权
    Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease 有权
    用于口服给药的吸附剂和用于治疗或预防肾或肝脏疾病的药剂

    公开(公告)号:US08357366B2

    公开(公告)日:2013-01-22

    申请号:US11547043

    申请日:2005-04-04

    IPC分类号: A61K33/44 A61K9/14

    CPC分类号: A61K33/44 Y10T428/2991

    摘要: An adsorbent for an oral administration, comprising a surface-modified spherical activated carbon wherein an average particle diameter is 50 to 200 μm, a specific surface area determined by a BET method is 700 m2/g or more, a bulk density is less than 0.54 g/mL, a total amount of acidic groups is 0.30 to 1.20 meq/g, and a total amount of basic groups is 0.20 to 0.9 meq/g is disclosed. The adsorbent for an oral administration has a high adsorbability, and is capable of adsorbing a large amount of toxins during a retention period in an intestine, and of remarkably reducing an amount of urinary proteins excretion.

    摘要翻译: 用于口服给药的吸附剂,其包含平均粒径为50〜200μm的表面改性的球形活性炭,BET法测定的比表面积为700m 2 / g以上,堆积密度小于0.54 g / mL,酸性基团的总量为0.30〜1.20meq / g,碱性基团的总量为0.20〜0.9meq / g。 用于口服的吸附剂具有高的吸附性,并且能够在保留期间在肠中吸附大量的毒素,并且显着减少尿蛋白排泄量。

    Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
    7.
    发明申请
    Adsorbent for oral administration, and agent for treating or preventing renal or liver disease 有权
    用于口服的吸附剂和用于治疗或预防肾或肝脏疾病的药剂

    公开(公告)号:US20050112114A1

    公开(公告)日:2005-05-26

    申请号:US10969998

    申请日:2004-10-22

    CPC分类号: A61K33/44 Y10S514/893

    摘要: An adsorbent for an oral administration, comprising a surface-modified spherical activated carbon wherein an average diameter is 0.01 to 1 mm, a specific surface area determined by a BET method is 700 m2/g or more, a volume of pores having a pore diameter of 7.5 to 15000 nm is from 0.25 mL/g to 1.0 mL/g, a total amount of acidic groups is 0.30 to 1.20 meq/g, and a total amount of basic groups is 0.20 to 0.7 meq/g, is disclosed.

    摘要翻译: 一种用于口服给药的吸附剂,其包含平均直径为0.01至1mm的表面改性的球形活性炭,通过BET法测定的比表面积为700m 2 / g以上, 孔径为7.5〜15000nm的孔体积为0.25mL / g〜1.0mL / g,酸性基团的总量为0.30〜1.20meq / g,碱性基团的总量为0.20〜0.7 meq / g。

    Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease
    8.
    发明授权
    Adsorbent for an oral administration, and agent for treating or preventing renal or liver disease 有权
    用于口服给药的吸附剂和用于治疗或预防肾或肝脏疾病的药剂

    公开(公告)号:US08865161B2

    公开(公告)日:2014-10-21

    申请号:US13490405

    申请日:2012-06-06

    IPC分类号: A61K33/44 A61K9/14

    CPC分类号: A61K33/44 Y10T428/2991

    摘要: An adsorbent for an oral administration, comprising a surface-modified spherical activated carbon wherein an average particle diameter is 50 to 200 μm, a specific surface area determined by a BET method is 700 m2/g or more, a bulk density is less than 0.54 g/mL, a total amount of acidic groups is 0.30 to 1.20 meq/g, and a total amount of basic groups is 0.20 to 0.9 meq/g is disclosed. The adsorbent for an oral administration has a high adsorbability, and is capable of adsorbing a large amount of toxins during a retention period in an intestine, and of remarkably reducing an amount of urinary proteins excretion.

    摘要翻译: 用于口服给药的吸附剂,其包含平均粒径为50〜200μm的表面改性的球形活性炭,BET法测定的比表面积为700m 2 / g以上,堆积密度小于0.54 g / mL,酸性基团的总量为0.30〜1.20meq / g,碱性基团的总量为0.20〜0.9meq / g。 用于口服的吸附剂具有高的吸附性,并且能够在保留期间在肠中吸附大量的毒素,并且显着减少尿蛋白排泄量。

    Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease
    9.
    发明申请
    Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease 有权
    用于口服给药的吸附剂和用于治疗或预防肾脏或肝脏疾病的药剂

    公开(公告)号:US20080081073A1

    公开(公告)日:2008-04-03

    申请号:US11547043

    申请日:2005-04-04

    CPC分类号: A61K33/44 Y10T428/2991

    摘要: An adsorbent for an oral administration, comprising a surface-modified spherical activated carbon wherein an average particle diameter is 50 to 200 μm, a specific surface area determined by a BET method is 700 m2/g or more, a bulk density is less than 0.54 g/mL, a total amount of acidic groups is 0.30 to 1.20 meq/g, and a total amount of basic groups is 0.20 to 0.9 meq/g is disclosed. The adsorbent for an oral administration has a high adsorbability, and is capable of adsorbing a large amount of toxins during a retention period in an intestine, and of remarkably reducing an amount of urinary proteins excretion.

    摘要翻译: 一种用于口服给药的吸附剂,其包含平均粒径为50至200μm的表面改性的球形活性炭,通过BET法测定的比表面积为700m 2 / g以上 ,堆积密度小于0.54g / mL,酸性基团的总量为0.30〜1.20meq / g,碱性基团的总量为0.20〜0.9meq / g。 用于口服的吸附剂具有高的吸附性,并且能够在保留期间在肠中吸附大量的毒素,并且显着减少尿蛋白排泄量。

    Process For Manufacturing Spherical Activated Carbon
    10.
    发明申请
    Process For Manufacturing Spherical Activated Carbon 审中-公开
    制造球形活性炭的工艺

    公开(公告)号:US20080031972A1

    公开(公告)日:2008-02-07

    申请号:US11547501

    申请日:2005-04-04

    IPC分类号: A61K33/44 C01B31/02

    摘要: A process for manufacturing a spherical activated carbon, characterized by comprising the steps of: (1) forming a spherical substance of a heat-fusible resin, (2) oxidizing the spherical substance of a heat-fusible resin to form a heat-infusible spherical substance, and (3) activating the heat-infusible spherical substance to form the spherical activated carbon is disclosed. According to the process for the manufacture, a spherical activated carbon having desirable properties, such as an average particle diameter, a particle size distribution, a pore volume, or a specific surface area, can be easily prepared.

    摘要翻译: 一种制造球形活性炭的方法,其特征在于包括以下步骤:(1)形成热熔性树脂的球形物质,(2)将可热熔树脂的球形物质氧化以形成热熔融球形 物质,和(3)激活热不熔球形成球形活性炭。 根据制造方法,可以容易地制备具有所需性质如平均粒径,粒度分布,孔体积或比表面积的球形活性炭。